Cipla USA Tech Stack
Generic drug manufacturer with respiratory and specialty pharma focus across US sites
Cipla USA operates three manufacturing plants across the Northeast, producing generic drugs and inhalation therapies with an embedded quality and manufacturing engineering footprint. The tech stack is heavily automation and instrumentation-based (SCADA, PLC, MES, LPLC, UPLC, LC-MS), reflecting a regulated-manufacturing operation managing complex analytical and process-control workflows. Active hiring concentrates on manufacturing and quality roles across mid-to-junior levels, while project focus spans enterprise systems implementation, data integrity remediation, and production-line automation—a pattern that suggests modernizing legacy manufacturing IT infrastructure while addressing CGMP compliance gaps.
Tech Stack 17 technologies
What Cipla USA Is Building
◆Challenges
- Implementing it infra and security solutions
- Reducing downtime
- Reducing cost and safety hazards
- Identifying gaps in system
- Operational inefficiencies
- Data integrity gaps
- Reducing maintenance costs
- Driving data standards
- Reducing time spent during changeovers
- Reducing time spent preparing lines
▲Active Projects
- Enterprise application architecture
- Capa implementation
- Implementing new technologies and automation in production workflows
- Systems implementation
- Data integrity risk assessment of cgmp and glp systems
- Implementing waters/master control solutions
- Cleaning and process validation of api equipment
- Continuous improvements to the change control system
- Scaling applications across regions
- Launch planning
Hiring Activity
Department
Seniority
Notable leadership hires: Procurement Director, Production Section Head, Packaging Section Head
